Form D · Other Technology
Keensight Health Inc.
Bellevue, WA · CIK 0002126519
Offering snapshot reported Apr 2, 2026 · SEC filing
- Reported sold
- $70K Offering amount: $1.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2026 | Initial | $70,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-578921
Source: Form D, filed Apr 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aamir Allaqaband | Director, Executive, Promoter |
| Ian Bennett | Director, Promoter |
| Misbah Keen | Director, Promoter |
| Jingcong Zhao | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
4228 146 Th Ave Se
Bellevue, WA, 98006
Bellevue, WA, 98006